Clinical Trial Update: SPCG17: Prostate Cancer Active Surveillance Trigger Trial [NA]

View source ↗

Summary

A clinical trial update indicating SPCG17, a prostate cancer active surveillance trigger trial, is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Uppsala University | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING